Government plans to sell more than 400 generic medicines at cheaper price through Jan Aushadhi stores by end of this year.
At present, there are 225 generic medicines available at Jan Aushadhi store. The rates of medicine on these stores are as low as one-third to one-tenth of the market price depending on the type of medicine.
Ahir said the ministry will provide quality generic medicines to all, especially the poor, including medicines used for treating diabetes, cancer and cardiovascular diseases.
Also Read
Speaking while inaugurating the Jan Aushadhi store Ahir said, "We will increase the number of generic medicines to 425 from 225 at present which will also include medicines treating for diabetes and cancer among others."
The government is also planning to increase the number Jan Aushadhi stores to 3000 that will be opened in two years across the country by involving B Pharma and M Pharma qualified unemployed populace.
The government has been selling generic medicines at affordable prices in the name of Jan Aushadhi medicines since 2008.
In February this year, the government decided to permit sale of Jan Aushadhi Medicines through private retailers in addition to Government hospitals and Jan Aushadhi Stores in order to expand the network of sale and to reach out to all sections of the society.
The Pre-Congress hosted top pharmaceutical leaders such D
G Shah, Secretary General, IPA; Sharad Tyagi, Managing Director, Boehringer Ingelheim; Srini Srinivasan, Managing Director , Hospira Healthcare Pvt Ltd - A Pfizer Company; Sanjit Singh Lamba, Managing Director, Eisai Pharmaceuticals; CT. Renganathan, Managing Director, RPG Lifesciences; Krishna Prasad Chigurupati, Founder and Managing Director, Granules India; Vivek Sharma, CEO , Piramal Pharma Solutions & Critical Care; Ashok Bhattacharya, Managing Director, Takeda Pharmaceuticals; G. Munjal, Managing Director & CEO, Ind-swift laboratories; and Satya Karm Punia, Managing Director, Camus Pharma; among others to present their unique insights on the discussions.
Other key upcoming events revolving around the India Pharma Week include The Women in Pharma-Power Breakfast session on November 18 that will address the fact that despite advancements, women still comprise only 15 percent of the total workforce in the Indian pharma industry. The talks will be chaired by women who have broken the glass ceiling in the pharma sector such as Samina Vaziralli, Executive Vice-Chairman, Cipla; Dr Anurita Majumdar, Sr Medical Director & Global Established Pharma Medical Lead, Pfizer; and Dr Rashmi Hegde, Director - Medical, Abbott, among others. Slated for the evening of November 18 is the India Pharma Awards, an endeavour that recognizes and celebrates the excellence, achievements and innovations of pharma industry stalwarts along with networking opportunities, presentations and glamorous entertainment acts.
